Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
Year: 2021
Type: article
Abstract: The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.
Source: Cephalalgia
Institutions: University of Duisburg-Essen, University of Copenhagen, Rigshospitalet, Inserm, Université Paris Cité, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Centre de Recherche Épidémiologie et Statistique, Charité – Universitätsmedizin Berlin, Centre Hospitalier Universitaire de Nice, Albert Einstein College of Medicine, Tufts Medical Center, Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, University of Pavia, Fondazione Istituto Neurologico Nazionale Casimiro Mondino, Leiden University Medical Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W3124105261